1. Canada Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Lifeist Wellness Inc

Lifeist Wellness Inc

0.06
CAD
+0.00
(-7.69%)
-0.15EPS
1.52MMarket Cap
Oct 23Next Earn
Lifeist Wellness Inc
NEO:LFST
(Cboe Canada)

Recent

price

0.06

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CAD
- -
- -
- -
- -
0.22
2.52
1.31
1.57
1.49
1.02
1.55
1.08
1.06
0.06
0.02
0.01
0.01
Revenue per Share
-1.1
-2.82
-0.55
-0.36
-1.24
0.2
-0.81
-2.48
-1.86
-3.95
-1.62
-1.22
-0.74
-0.58
-0.05
-0.08
-0.15
Basic EPS, GAAP
-2.05
-1.62
-0.28
-0.16
-0.52
0.1
-0.63
-1.16
-1.15
-2.52
-1.73
-0.96
-0.77
-0.1
-0.03
-0.08
-0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
2.53
1.63
1.1
0.81
0.02
0.32
0.5
1.24
4.64
3.45
1.81
1.29
0.64
0.12
0.11
0.03
0.02
Book Value per Share
2.53
1.63
1.1
0.81
0.02
0.32
-0.35
0.27
2.85
2.94
1.39
1
0.54
0.06
0.1
0.03
0.02
Tangible Book Value per Share
- -
1
1
1
1
2
3
7
12
16
16
20
21
24
32
38
38
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
5
3
11
19
16
25
21
22
1
1
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
-311.15
13.67
-57.84
-74.92
-118.77
-165.96
-104.36
-112.38
-67.09
-453.3
-753.04
-961.1
-518.91
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
2
3
2
2
1
- -
- -
- -
- -
Depreciation Expense
- -
-2
- -
- -
-1
- -
-2
-17
-23
-63
-26
-24
-15
-14
-1
-3
-6
Net Income, GAAP
- -
- -
- -
- -
- -
39.68
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
-575.04
7.78
-61.69
-158.06
-125.11
-386.57
-104.56
-112.56
-69.94
-1,034.86
-245.51
-1,198.99
-2,007.97
Profit Margin (%)
1
1
- -
- -
- -
- -
- -
4
39
39
17
16
8
- -
3
1
1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
1
- -
- -
- -
LT Debt
1
1
1
1
- -
- -
2
12
66
56
29
26
13
3
4
1
1
Total Equity
- -
- -
- -
- -
- -
123.73
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
188.14
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-54.28
-170.31
-40.34
-37.81
-341
188.14
-211.18
-262.71
-60.13
-103.92
-61.68
-86.05
-78.3
-167.93
-38.39
-114.57
-431.41
Return on Common Equity (%)

Capital Structure

CAD

•

in mil. unless spec.
Nov'25
Feb'26
May'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
38
38
38
Market Capitalization
2
2
2

Working Capital

CAD

•

in mil. unless spec.
Nov'25
Feb'26
May'26
Total Current Assets
2
1
1
Cash, Cash Equivalents & STI
1
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
- -
- -
Payables & Accruals
1
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
118.27%
-37.4%
-71.84%
Free Cash Flow
-36.82%
6.86%
230.56%
Net Income, GAAP
11.2%
-7.18%
106.83%
Sales/Revenue/Turnover
8.21%
-43.95%
-57.65%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
-10
1
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.09
-0.06
-0.09
- -
-0.05
2025
-0.04
-0.02
0.02
-0.15
-0.08
2026
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Lifeist Wellness Inc. operates as a health-focused technology enterprise across North America and internationally, dedicated to advancing human well-being through scientific and technological innovations. Its core asset is Mikra Cellular Sciences Inc., a United States biosciences subsidiary creating and distributing advanced wellness products for cellular health, including its flagship Glutathione+ supplement and other performance-focused formulations for cognitive and emotional well-being. These nutraceutical products are made available to consumers through various channels, notably Amazon.com. Within Canada, the company’s CannMart Inc. subsidiary functions as a business-to-business wholesale distributor of both licensed and internally developed adult-use cannabis and cannabis-derived items. This segment encompasses CannMart Labs, a specialized butane hash oil extraction facility producing in-house brands such as Roilty, and extends to include exports of cannabis products to markets like Australia. Additionally, the company supplies vaporizers and related accessories through its Australian Vapes platform. Formed in 2005, the Vancouver, Canada-headquartered organization transitioned from its previous identity, Namaste Technologies Inc., to Lifeist Wellness Inc. in September 2021.